Landscapes / Targets
pan-RAF
1 drug acts on pan-RAF, in 4 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Raf kinase inhibitor |
Erasca +1 |
Phase 3 | 2 Feb 2027Phase 2 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | 2 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | EGFR-mutant Non-small Cell Lung Cancer, Melanoma and 2 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 1 of 1 drug. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026